Drug Discovery

General context

This training on drug discovery will acquaint the attendees with challenges, opportunities and latest developments in drug discovery.
The training will start with a keynote talk during which a broad overview of the drug discovery field and the drug development pipeline will be given. In the first session, we will address the importance of target selection and validation in drug discovery, crucial issues to improve success rates in clinical trials. Next, we will focus on different approaches for small molecule discovery, such as high-throughput screening, phenotypic screening and fragment-based lead discovery. Additionally, drug discovery based on biologics will be discussed, encompassing the latest innovations in developing antibodies and recombinant proteins. We will end this training by highlighting new approaches in therapy, i.e. the potential of cell therapy and genome editing. Over the different sessions, fundamental concepts governing drug pharmacokinetics and pharmacodynamics will also be dealt with as they are critical elements of new drug discovery, and improvements of successful drug development.

Target Audience

This training targets scientists who want to learn more about the different steps in the drug discovery process. It is aimed at PhD students, postdoctoral fellows, technicians or other scientists with a molecular biology background.


Scientific Committee

Peter Tompa (VIB-VUB Center for Structural Biology)
Jo Van Ginderachter (VIB-VUB Center for Inflammation Research)
Wolfgang Fecke (VIB Discovery Sciences)

Confirmed speakers

Herman van Vlijmen, Janssen Pharmaceutical Companies of Johnson & Johnson, BE
Rafal Kaminski, UCB, BE
Matthias Versele, Center for Drug Design and Discovery, BE
Gyorgy Keseru, Research Centre for Natural Sciences, Hungarian Academy of Sciences, HU
Jonathan Lee, Eli Lilly and Co, San Diego, US
Erik Depla, Orionis Biosciences, Ghent, BE
Bert Schepens, VIB-UGent Center for Medical Biotechnology, BE
Evelien Smits, Center for Oncological Research, University of Antwerp, BE
Thierry Van Den Driessche, Department of Gene Therapy & Regenerative Medicine, VUB, BE



Registration info

  • Participation is free for VIB participants.
  • Registration fee for Academics from Universities and Centers of Excellence is € 40 (21% VAT incl.).
  • Registration fee for participants of EU-LIFE partner institutes is € 40 (21% VAT incl.).
  • Registration fee for industry is € 300 (21% VAT incl.).
  • Note that upon no-show without valid justification you will be blacklisted for the VIB training program for 1 year and for VIB participants the reimbursement of the catering costs (€ 40) will be charged to the research group. Click here for more information.


1 March 2018


Provinciehuis Vlaams-Brabant
Provincieplein 1
3010 Leuven


International and regional field experts
Registration is closed.

Registration start date:

1 December 2017

Registration end date:

14 February 2018